FBInvestor
Stocks / Travere Therapeutics Inc
Institutional Ownership

Travere Therapeutics Inc

CUSIP 89422GAA5NOTE 2.250% 3/0TVTXQ1 2026

No short-interest data on record yet

FINRA publishes consolidated short interest twice a month. Coverage expands as the bi-monthly feed runs.